September 18, 2024 Dataset Open Access

Gündel, Daniel; Teodoro, Rodrigo; c, Friedrich-Alexander Ludwig a.; Heerklotz a., Anne; Toussaint, Magali; Deuther-Conrad, Winnie; Bormans d., Guy; Brust a., Peter; Kopka, Klaus; Moldovan, Rares-Petru; f, Rareş-Petru Moldovan

JSON-LD (schema.org) Export

{
  "@type": "Dataset", 
  "@context": "https://schema.org/", 
  "name": "Data publication: Development and Evaluation of Deuterated [18F]JHU94620 Isotopologues for the Non-invasive Assessment of the Cannabinoid type 2 Receptor in Brain", 
  "identifier": "https://doi.org/10.14278/rodare.3149", 
  "sameAs": [
    "https://www.hzdr.de/publications/Publ-39600"
  ], 
  "creator": [
    {
      "name": "G\u00fcndel, Daniel", 
      "@id": "https://orcid.org/0000-0001-9743-2325", 
      "@type": "Person"
    }, 
    {
      "name": "Teodoro, Rodrigo", 
      "@type": "Person"
    }, 
    {
      "name": "c, Friedrich-Alexander Ludwig a.", 
      "@type": "Person"
    }, 
    {
      "name": "Heerklotz a., Anne", 
      "@type": "Person"
    }, 
    {
      "name": "Toussaint, Magali", 
      "@id": "https://orcid.org/0000-0002-1136-3857", 
      "@type": "Person"
    }, 
    {
      "name": "Deuther-Conrad, Winnie", 
      "@id": "https://orcid.org/0000-0003-3168-3062", 
      "@type": "Person"
    }, 
    {
      "name": "Bormans d., Guy", 
      "@type": "Person"
    }, 
    {
      "name": "Brust a., Peter", 
      "@type": "Person"
    }, 
    {
      "name": "Kopka, Klaus", 
      "@id": "https://orcid.org/0000-0003-4846-1271", 
      "@type": "Person"
    }, 
    {
      "name": "Moldovan, Rares-Petru", 
      "@id": "https://orcid.org/0000-0003-3119-7945", 
      "@type": "Person"
    }, 
    {
      "name": "f, Rare\u015f-Petru Moldovan", 
      "@type": "Person"
    }
  ], 
  "datePublished": "2024-09-18", 
  "@id": "https://doi.org/10.14278/rodare.3149", 
  "url": "https://rodare.hzdr.de/record/3149", 
  "license": "https://creativecommons.org/licenses/by/4.0/legalcode", 
  "description": "<p>What is already known &bull; Increased expression of the CB2R in the brain is linked to certain neuropathological diseases. &bull; First clinical trials for CB2R-directed therapies are conducted. What this study adds &bull; [18F]JHU94620-d8 provides the potential to quantify the CB2R receptor density in the brain by positron-emission-tomography. Clinical significance &bull; Stratification of patients for CB2R-directed therapies and follow up of the treatment response is needed.</p>", 
  "distribution": [
    {
      "contentUrl": "https://rodare.hzdr.de/api/files/28e31c73-6bd4-4b8a-9bf3-08c3a2a18e73/18FJHU94620_gammacounter_results15Jan2020.xlsx", 
      "@type": "DataDownload", 
      "fileFormat": "xlsx"
    }
  ]
}